2017
DOI: 10.1097/rlu.0000000000001665
|View full text |Cite
|
Sign up to set email alerts
|

Blastic Plasmacytoid Dendritic Cell Neoplasm Evaluated by FDG PET/CT

Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy. A 34-year-old man with a biopsy-proven BPDCN underwent FDG PET/CT for staging. FDG PET/CT revealed multiple mild FDG-avid cutaneous lesions on the chest and back, involvement of left inguinal lymph node, and a markedly increased FDG-avid subcutaneous mass in the left lower leg.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…On the axial images of PET, CT and PET/CT fusion, enlarged lymph nodes were observed in mediastinum (B,C), and abdominal and pelvic cavity (D,E) (arrows), which demonstrated intense 18 F-FDG uptake with the highest SUVmax of 13.9 in the mesenteric lymph node. node, bone marrow, and other organs, which is related to prognosis of the disease (5,17).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the axial images of PET, CT and PET/CT fusion, enlarged lymph nodes were observed in mediastinum (B,C), and abdominal and pelvic cavity (D,E) (arrows), which demonstrated intense 18 F-FDG uptake with the highest SUVmax of 13.9 in the mesenteric lymph node. node, bone marrow, and other organs, which is related to prognosis of the disease (5,17).…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis of BPDCN is mainly based on histology, immunohistochemistry, and flow cytometry (3,4). 18 F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography ( 18 F-FDG PET/CT) is helpful in staging of BPDCN (5). Given the highly aggressive clinical behavior, the overall prognosis of BPDCN is poor (6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…CT has been mainly used to assess the extent and depth of the skin lesions, as well as the metastases in patients with BPDCN [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] . CT shows round and ovoid homogeneous cutaneous mass with soft tissue density with or without subcutaneous invasion as seen in the present case.…”
Section: Discussionmentioning
confidence: 99%
“…Rapid progression to the terminal leukemic phase is common, resulting in a short mean survival of 12–16 months [3] . To our knowledge, there have been at least 11 reports with CT findings [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , including 4 18 F- fluorodeoxyglucose positron emission tomography / CT ( 18 F-FDG PET/CT) reports, associated with BPDCN; however, knowledge of chronological changes on sequential CT examinations have been limited [ 13 , 14 ]. We herein report a case of a patient with rapidly progressing BPDCN with a sequential evaluation on CT.…”
Section: Introductionmentioning
confidence: 99%
“…FDG PET-CT monitoring was performed on a male with prostatic hyperplasia. FDG PET showed several slight FDG-like skin lesions in chest and back, involving left inguinal lymph nodes, and obvious FDG-like subcutaneous mass in left calf [7]. Sauerland thinks that the statement that "PET is better than tomography" is too optimistic and needs further and more reliable tests to confirm [8].…”
Section: Introductionmentioning
confidence: 99%